Virios Therapeutics (NASDAQ:VIRI) Trading Up 0.1% - What's Next?

Key Points

• Virios Therapeutics' stock experienced a slight increase of 0.1%, trading at $4.87 with a market cap of $93.69 million.
• The company is developing a lead candidate, IMC-1, a combination therapy targeting fibromyalgia.
• Trading volume was notably low, decreasing by 99% compared to its average session volume.

Virios Therapeutics, Inc. (NASDAQ:VIRI - )'s stock price shot up 0.1% on Thursday . The stock traded as high as $4.95 and last traded at $4.87. 8,989 shares were traded during mid-day trading, a decline of 99% from the average session volume of 1,049,645 shares. The stock had previously closed at $4.86.

Virios Therapeutics Trading Up 0.1%

The company's 50 day moving average price is $4.88 and its two-hundred day moving average price is $5.80. The stock has a market cap of $93.69 million, a P/E ratio of -18.02 and a beta of 1.58.

Virios Therapeutics Company Profile

Virios Therapeutics, Inc, a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.